Business, energy, technology, markets and global industry news from Business News Today

COMMENCE trial

PharmaDeviceNews COMMENCE trial
Representative image: A bioprosthetic aortic valve in a surgical setting highlights the growing focus on long-term heart valve durability as Edwards Lifesciences’ 10-year RESILIA tissue data sharpen the debate over lifetime valve planning in aortic stenosis care.
Medical Devices & Diagnostics

Edwards Lifesciences’ RESILIA data may shift the valve debate, but not without caveats

Valve durability is becoming a lifetime-care question. Edwards Lifesciences’ 10-year RESILIA data raise the stakes for heart teams.

Read More